vs
Side-by-side financial comparison of HUTCHMED (China) Ltd (HCM) and Verisign (VRSN). Click either name above to swap in a different company.
Verisign is the larger business by last-quarter revenue ($425.3M vs $270.8M, roughly 1.6× HUTCHMED (China) Ltd). Verisign runs the higher net margin — 48.5% vs 0.7%, a 47.8% gap on every dollar of revenue. On growth, Verisign posted the faster year-over-year revenue change (7.6% vs -16.5%). Verisign produced more free cash flow last quarter ($285.1M vs $3.4M).
HUTCHMED (China) LtdHCMEarnings & Financial Report
HUTCHMED (China) Ltd is a biopharmaceutical firm focused on discovering, developing and commercializing targeted and immunotherapies for oncology and immunological diseases. It operates across China and global markets, with multiple marketed oncology drugs and a robust pipeline of late-stage clinical candidates addressing unmet patient needs.
Verisign, Inc. is an American company based in Reston, Virginia, that operates a diverse array of network infrastructure, including two of the Internet's thirteen root nameservers, the authoritative registry for the .com, .net, and .name generic top-level domains and the .cc country-code top-level domains, and the back-end systems for the .jobs and .edu sponsored top-level domains.
HCM vs VRSN — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | ||
|---|---|---|
| Revenue | $270.8M | $425.3M |
| Net Profit | $2.0M | $206.2M |
| Gross Margin | 37.7% | 88.5% |
| Operating Margin | -13.2% | 67.0% |
| Net Margin | 0.7% | 48.5% |
| Revenue YoY | -16.5% | 7.6% |
| Net Profit YoY | -83.6% | 7.7% |
| EPS (diluted) | $0.00 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $270.8M | $425.3M | ||
| Q3 25 | — | $419.1M | ||
| Q2 25 | $277.7M | $409.9M | ||
| Q1 25 | $324.5M | $402.3M | ||
| Q4 24 | — | $395.4M | ||
| Q3 24 | — | $390.6M | ||
| Q2 24 | $305.7M | $387.1M | ||
| Q1 24 | — | $384.3M |
| Q4 25 | $2.0M | $206.2M | ||
| Q3 25 | — | $212.8M | ||
| Q2 25 | $455.0M | $207.4M | ||
| Q1 25 | $11.9M | $199.3M | ||
| Q4 24 | — | $191.5M | ||
| Q3 24 | — | $201.3M | ||
| Q2 24 | $25.8M | $198.8M | ||
| Q1 24 | — | $194.1M |
| Q4 25 | 37.7% | 88.5% | ||
| Q3 25 | — | 88.4% | ||
| Q2 25 | 0.1% | 88.0% | ||
| Q1 25 | 48.0% | 87.7% | ||
| Q4 24 | — | 87.8% | ||
| Q3 24 | — | 88.0% | ||
| Q2 24 | 41.1% | 87.8% | ||
| Q1 24 | — | 87.2% |
| Q4 25 | -13.2% | 67.0% | ||
| Q3 25 | — | 67.8% | ||
| Q2 25 | -1.3% | 68.5% | ||
| Q1 25 | -5.0% | 67.4% | ||
| Q4 24 | — | 66.7% | ||
| Q3 24 | — | 68.9% | ||
| Q2 24 | -9.0% | 68.8% | ||
| Q1 24 | — | 67.4% |
| Q4 25 | 0.7% | 48.5% | ||
| Q3 25 | — | 50.8% | ||
| Q2 25 | 163.8% | 50.6% | ||
| Q1 25 | 3.7% | 49.5% | ||
| Q4 24 | — | 48.4% | ||
| Q3 24 | — | 51.5% | ||
| Q2 24 | 8.4% | 51.4% | ||
| Q1 24 | — | 50.5% |
| Q4 25 | $0.00 | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $0.52 | — | ||
| Q1 25 | $0.01 | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $0.03 | — | ||
| Q1 24 | — | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.4B | $580.5M |
| Total DebtLower is stronger | $93.2M | — |
| Stockholders' EquityBook value | $1.2B | $-2.2B |
| Total Assets | $1.8B | $1.3B |
| Debt / EquityLower = less leverage | 0.08× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.4B | $580.5M | ||
| Q3 25 | — | $617.7M | ||
| Q2 25 | $1.4B | $593.8M | ||
| Q1 25 | $836.1M | $648.5M | ||
| Q4 24 | — | $599.9M | ||
| Q3 24 | — | $644.9M | ||
| Q2 24 | $802.5M | $689.9M | ||
| Q1 24 | — | $924.7M |
| Q4 25 | $93.2M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $93.4M | — | ||
| Q1 25 | $82.8M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $82.1M | — | ||
| Q1 24 | — | — |
| Q4 25 | $1.2B | $-2.2B | ||
| Q3 25 | — | $-2.1B | ||
| Q2 25 | $1.2B | $-2.0B | ||
| Q1 25 | $759.9M | $-2.0B | ||
| Q4 24 | — | $-2.0B | ||
| Q3 24 | — | $-1.9B | ||
| Q2 24 | $740.1M | $-1.8B | ||
| Q1 24 | — | $-1.6B |
| Q4 25 | $1.8B | $1.3B | ||
| Q3 25 | — | $1.4B | ||
| Q2 25 | $1.8B | $1.4B | ||
| Q1 25 | $1.3B | $1.4B | ||
| Q4 24 | — | $1.4B | ||
| Q3 24 | — | $1.5B | ||
| Q2 24 | $1.3B | $1.5B | ||
| Q1 24 | — | $1.7B |
| Q4 25 | 0.08× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 0.08× | — | ||
| Q1 25 | 0.11× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 0.11× | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $8.2M | $289.6M |
| Free Cash FlowOCF − Capex | $3.4M | $285.1M |
| FCF MarginFCF / Revenue | 1.2% | 67.0% |
| Capex IntensityCapex / Revenue | 1.8% | 1.1% |
| Cash ConversionOCF / Net Profit | 4.21× | 1.40× |
| TTM Free Cash FlowTrailing 4 quarters | $-96.2M | $1.1B |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $8.2M | $289.6M | ||
| Q3 25 | — | $307.7M | ||
| Q2 25 | $-72.9M | $202.5M | ||
| Q1 25 | $40.3M | $291.3M | ||
| Q4 24 | — | $231.5M | ||
| Q3 24 | — | $253.4M | ||
| Q2 24 | $-39.8M | $160.4M | ||
| Q1 24 | — | $257.3M |
| Q4 25 | $3.4M | $285.1M | ||
| Q3 25 | — | $303.0M | ||
| Q2 25 | $-82.2M | $194.7M | ||
| Q1 25 | $32.5M | $285.5M | ||
| Q4 24 | — | $222.0M | ||
| Q3 24 | — | $247.8M | ||
| Q2 24 | $-49.9M | $151.2M | ||
| Q1 24 | — | $253.5M |
| Q4 25 | 1.2% | 67.0% | ||
| Q3 25 | — | 72.3% | ||
| Q2 25 | -29.6% | 47.5% | ||
| Q1 25 | 10.0% | 71.0% | ||
| Q4 24 | — | 56.1% | ||
| Q3 24 | — | 63.4% | ||
| Q2 24 | -16.3% | 39.1% | ||
| Q1 24 | — | 66.0% |
| Q4 25 | 1.8% | 1.1% | ||
| Q3 25 | — | 1.1% | ||
| Q2 25 | 3.3% | 1.9% | ||
| Q1 25 | 2.4% | 1.4% | ||
| Q4 24 | — | 2.4% | ||
| Q3 24 | — | 1.4% | ||
| Q2 24 | 3.3% | 2.4% | ||
| Q1 24 | — | 1.0% |
| Q4 25 | 4.21× | 1.40× | ||
| Q3 25 | — | 1.45× | ||
| Q2 25 | -0.16× | 0.98× | ||
| Q1 25 | 3.38× | 1.46× | ||
| Q4 24 | — | 1.21× | ||
| Q3 24 | — | 1.26× | ||
| Q2 24 | -1.54× | 0.81× | ||
| Q1 24 | — | 1.33× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.